Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
株式のランク #38669
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
株価
$0.04057595
最終同期: 2024-08-05
時価総額
$863.62K
変化(1日)
0.31%
変化(1年)
0.00%
SE
取引 AegirBio AB (publ) (AEGIR)

カテゴリー

AegirBio AB (publ)(AEGIR)の利益
Sep 2024 時点の利益 TTM: $-3.81M
AegirBio AB (publ) の最新の財務報告によると、同社の現在の利益は $-3.81M です。2022 年には $-34.94M の利益を上げ、これは 2021 年の利益 $-10.24M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
AegirBio AB (publ) の利益の推移(2019 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-3.81M -37.26%
2023 $-6.07M -82.64%
2022 $-34.94M 241.24%
2021 $-10.24M 36.29%
2020 $-7.51M 28,276,939.29%
2019 $-26.57 0.00%
同業他社の利益
企業 利益 利益の差
$3.81B -100,104.94%
US
$4.11B -108,067.95%
FR
- -
JP
$1.59B -41,880.40%
US
- -
CH